Understand the source comparison
SS-LUP-332 Research Review: Comparison of Study Findings
Before interpreting what existing data suggests, understanding the scope and limitations of each major study clarifies where conclusions are supported versus speculative. Washington University 2019 (Molecular Metabolism) Sedentary adult mice, 10 mg/kg SC daily
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before interpreting what existing data suggests, understanding the scope and limitations of each major study clarifies where conclusions are supported versus speculative.
- Washington University 2019 (Molecular Metabolism)
- Sedentary adult mice, 10 mg/kg SC daily × 28 days
- PGC-1α expression in skeletal muscle, mitochondrial density
- 52% increase in PGC-1α mRNA; 34% increase in mitochondrial density; 28% higher VO2; RER shift from 0.92 to 0.78 indicating fat oxidation preference
- No exercise training interaction tested; no long-term follow-up beyond 28 days; single dose level optimal
- Strongest mechanistic foundation. Demonstrates PGC-1α activation and functional metabolic shift, but duration too short to assess sustainability or adaptation
- Cell Metabolism 2021
- Aged mice (18 months), 10 mg/kg SC daily × 12 weeks
- Age-related mitochondrial decline, physical function, oxidative stress markers
- 38% grip strength improvement; 24% increase in voluntary activity; 19% reduction in DNA damage markers; partial reversal of age-related mitochondrial loss
- Aged mice are not equivalent to metabolically diseased humans; no comparison with exercise intervention; dropout rate not reported
- Suggests potential application beyond weight loss to age-related metabolic decline. But extrapolation to human aging is highly uncertain
- J Biological Chemistry 2023
- Adult mice on high-fat diet, 10 mg/kg SC daily × 8 weeks
- White adipose tissue browning (UCP1 expression), thermogenesis, energy expenditure
- 67% increase in UCP1 in inguinal fat; 15% higher total energy expenditure; better cold tolerance; 40% less weight gain vs controls despite identical food intake
- Effect size in animals with higher baseline metabolic rate; thermoneutral housing temperature not specified; no human adipose tissue cultures tested
- Browning effect is mechanistically plausible and consistent with PGC-1α activation. But magnitude in humans likely smaller; subcutaneous vs visceral fat response unknown
- Bottom line: All three studies converge on PGC-1α-mediated mitochondrial activation as the central mechanism, with consistent dose-response at 10 mg/kg and no toxicity signals in rodent models. However, zero published human data means dosing, bioavailability, and real-world efficacy remain unknown as of 2026.